OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

NCT00258375 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: custirsen sodium
DRUG: docetaxel

Sponsor

NCIC Clinical Trials Group